Frontlight ResearchEarly access
Trial site
Santa Fe
- 8running trials
- 7closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy4 trials
- Chronic spontaneous urticaria3 trials
- Coronary artery disease3 trials
- Stroke3 trials
- Familial hypercholesterolaemia2 trials
- Chronic kidney disease1 trial
- Gastric and oesophageal cancer1 trial
- Heart failure1 trial
- High blood pressure1 trial
- Lupus (SLE)1 trial
- Pulmonary arterial hypertension1 trial
- Phase
- Phase 312 trials
- Phase 1/21 trial
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting6 trials
- Completed6 trials
- Recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Novartis Pharmaceuticals15 trials
Running trials
Active, not recruiting
Recruiting
Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
Recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- IgA nephropathy1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Completed
Terminated
Completed
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026